Abstract
BackgroundThe presence of semen in the vagina from unprotected sex may influence the immune and microbial environment of the female genital tract. Inflammatory cytokine concentrations and BV-associated bacteria in female genital secretions may influence HIV risk, although the effect of recent sexual intercourse on incident BV and the cytokine milieu of cervicovaginal secretions has rarely been measured in previous studies. Here, we investigated the extent to which partner semen impacts the cytokine response and incident BV.MethodsAt baseline, we assessed the recency of semen exposure in menstrual cup supernatants by quantifying prostate specific antigen (PSA) levels using ELISA in 248 HIV-uninfected women at high risk for HIV infection. Luminex was used to measure 48 cytokines in menstrual cup supernatants and vaginal swabs to diagnose BV by Nugent score. Point-of-care screening for Chlamydia trachomatis and Neisseria gonorrhoeae was conducted using GeneXpert while OSOM was used for Trichomonas vaginalis detection. Multivariable models, adjusted for age, sexually transmitted infections, BV, current contraception use and condom use, were used to assess the impact of semen exposure on biomarkers of inflammation and BV.ResultsPresence of PSA, indicating recent semen exposure within 48 hours prior to sampling, was observed in menstrual cup supernatants of 17% (43/248) of women. Of these women, 70% (30/43) had self-reported condom use at their last sex act and 84% (36/43) had BV (Nugent score >7). PSA presence was significantly associated with prevalent BV (Relative Risk (RR), 2.609; 95% Confidence Interval (CI), 1.104 - 6.165; p = 0.029). Furthermore, women with detectable PSA had high median concentrations of macrophage inflammatory protein- beta (MIP-1α, p=0.047) and low median concentration of the stem cell growth factor beta (SCGF-β, p=0.038) compared to those without PSA.ConclusionA degree of discordance between self-reports of consistent condom use and PSA positivity was observed. There was also evidence of a relationship between recent semen exposure, BV prevalence and altered cytokine concentrations. These findings suggest that PSA, as a semen biomarker, should be taken into consideration when investigating biological markers in the female genital tract and self-reported condom use in studies on reproductive and sexual health.
Highlights
Semen exposure through unprotected sexual intercourse as well as inconsistent and incorrect condom use may result in heterosexual transmission of HIV, likely by modulating the inflammatory response and altering optimal vaginal microbial communities of the female genital tract (FGT) [1,2,3,4]
In vitro studies of the endometrial epithelial cells showed that human seminal plasma decreased the secretions of innate antiviral factors, while increasing a cascade of inflammatory cytokines and chemokines (Granulocyte macrophage colony-stimulating factor (GM-CSF), IL-1 alpha (IL-1a), IL-1b, Growth regulating alpha (GROa), Macrophage inflammatory protein- alpha [MIP1a), macrophage inhibitory protein (MIP)-1b, MIP-3 alpha (MIP-3a)] as well as the chemokine ligand for CC chemokine receptor 6 (CCR6) receptor expressed by cluster of differentiation 4 (CD4+) T helper (Th)-17 cells and Langerhans cells [8, 11, 12, 14]
About 70% (30/43) of the women who reported any condom use with their partner to prevent STIs tested positive for prostate-specific antigen (PSA), suggesting that condom use was likely over-reported or they engaged in unprotected sexual intercourse 48 hours before sample collection
Summary
Semen exposure through unprotected sexual intercourse as well as inconsistent and incorrect condom use may result in heterosexual transmission of HIV, likely by modulating the inflammatory response and altering optimal vaginal microbial communities of the female genital tract (FGT) [1,2,3,4]. In vitro studies of the endometrial epithelial cells showed that human seminal plasma decreased the secretions of innate antiviral factors (e.g. secretory leukocyte protease inhibitor), while increasing a cascade of inflammatory cytokines and chemokines (Granulocyte macrophage colony-stimulating factor (GM-CSF), IL-1 alpha (IL-1a), IL-1b, Growth regulating alpha (GROa), Macrophage inflammatory protein- alpha [MIP1a), MIP-1b, MIP-3 alpha (MIP-3a)] as well as the chemokine ligand for CC chemokine receptor 6 (CCR6) receptor expressed by cluster of differentiation 4 (CD4+) T helper (Th)-17 cells and Langerhans cells [8, 11, 12, 14] Expression of these cytokines is known to trigger the recruitment and activation of susceptible cells [11], suggesting that semen can increase a woman’s susceptibility to HIV, or other sexually transmitted infections (STIs). We investigated the extent to which partner semen impacts the cytokine response and incident BV
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have